Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 100 participants.
Also called NCT06432452
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Registry
-
NCT06432452
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT06432452. Randomized; triple masking; primary purpose treatment. Start 2024-11-11 (actual); primary completion 2026-06-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm
- Acronym
- EDIT-CAS
- Condition
- Coronary Spasm
- Intervention (Drug)
- Endothelin Receptor Antagonist
- Intervention (Other)
- Placebo control
- Lead sponsor
- Radboud University Medical Center
- Collaborator
- UMC Utrecht
- Collaborator
- Catharina Ziekenhuis Eindhoven
- Collaborator
- Maasstad Hospital
Record details
- Record id
cardio:ct-nct06432452- Content hash
eda870963664cbbf32d872d9e699f0a56967461e61473ebf9566ac3273916a65